Lobular carcinoma in situ (LCIS) treatment in 4 Oncology clinics in Norway
4 clinics specializing in Oncology providing treatment of Lobular carcinoma in situ (LCIS) Lobular carcinoma in situ (LCIS) is a non-invasive breast cancer confined to the milk-producing lobules. It is not considered a true cancer but increases the risk of developing invasive breast cancer. Regular monitoring and preventive measures are often recommended. disease in Norway.
Sorted by:
Relevance
Rating
Relevance
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
1 nearby similar clinic in Norway
Perhaps you should consider 1 more clinic we have found nearby basing on your Location, Disease filters applied.
Clinics grouping by rating
Clinic with the highest rating of 4.2 — The University Hospital of North Norway (UNN) Tromsø in Tromsø, Norway, clinic with the most reviews number of 191 — Aleris Frogner in Oslo, Norway.
With rating 4.0 and over — 3 clinics .
Countries with the highest number of clinics treating the diseases:
Lobular carcinoma in situ (LCIS):
worldwide
774 clinics
India
42 clinics
Brazil
40 clinics
Mexico
34 clinics
Germany
33 clinics
United Kingdom
33 clinics
Related procedures:
Procedures are likely to be used for Lobular carcinoma in situ (LCIS) treatment:
Breast reconstruction after mastectomy,
Double preventive mastectomy,
Lumpectomy,
Needle biopsy,
and
Nipple and areola reconstruction
.